Transfection of anti-sense complementary DNA of human epidermal-growth- factor receptor attenuates the proliferation of human non-small-cell-lung- cancer cells

International Journal of Cancer

Volumn 81, Issue 3, 1999, Pages 471-478

  Fang, Kang ^a   Chen, Mei Hui ^a  

^a NATIONAL TAIWAN NORMAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY RNA; GAMMA UROGASTRONE; POLYDEOXYRIBONUCLEOTIDE SYNTHASE;

AMINO TERMINAL SEQUENCE; ARTICLE; AUTOCRINE EFFECT; BRAIN METASTASIS; CELL CYCLE; CELL PROLIFERATION; DOWN REGULATION; ENZYME ACTIVITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; PARACRINE SIGNALING; PHENOTYPE; PRIORITY JOURNAL; TARGET CELL;

EID: 0032891108     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0215(19990505)81:3<471::aid-ijc23>3.0.co;2-2     Document Type: Article

References (25)

1. AAROSSON, S.A., Growth factors and cancer. Science, 254, 1146-1153 (1993).
2. CARPENTER, G., STOSCHECK, C.M., PRESTON, Y.A. and DE LARCO, J.E., Antibodies to the epidermal growth factor receptor block the biological activities of sarcoma growth factor. Proc. nat. Acad. Sci. (Wash.), 80, 5627-5630 (1983).
3. CIARDIELLO, F., DIXIT, M., ISERNIA, G., DAMIANO, V., BIANCO, R., BIANCO, A., ARTEAGA, C.L. and TORTORA, G., Down-regulation of type I protein kinase A by transtection of human breast cancer cells with an epidermal growth factor receptor antisense expression vector. Breast Cancer Res. Treat., 47, 57-62 (1998).
4. DIXIT, M., YANG, J.-L., POIRIER, M.C., PRICE, J.O., ANDREWS, P.A. and ARTEAGA, C.L., Abrogation of cisplatin-induced programmed cell death in human breast cancer cells by epidermal growth factor antisense RNA. J. nat. Cancer Inst., 89, 365-373 (1997).
5. EGUCHI, Y., ITOH, T. and TOMIZAWA, J., Antisense RNA. Ann. Rev. Biochem., 60, 631-652 (1991).
6. FANG, K., An enhanced and sensitive autocrine stimulation by transforming growth factor-α is acquired in the brain metastatic variant of a human non-small cell lung cancer cell line. Brit. J. Cancer, 74, 1775-1781 (1996).
7. FUJIWARA, T., CAI, D.W., GEORGES, R.N., MUKHOPADHYAY, T., GRIMM, E.A. and ROTH, J., Therapeutic effect of a retroviral wild-type p53 expression vector in an orthotopic lung cancer model. J. nat. Cancer Inst. 86, 1458-1462 (1994a).
8. FUJIWARA, T., MUKHOPADHYAY, T., CAI, D.W., MORRIS, D.K., ROTH, J. and GRIMM, E.A., Retroviral-mediated transduction of p53 gene increases TGF-β expression in a human glioblastonia cell line. Int. J. Cancer, 56, 834-839 (1994b).
9. GIOVANNI, C.D., LANDUZZI, L., FRABETTI, F., NICOLETTI, G., GRIFFONI, C., ROSSI, L., MAZZOTTI, M., SCOTTO, L., NANNI, P. and LOLLINI, P.-L., Antisense epidermal growth factor receptor transfection impairs the proliferative ability of human rhabdomyosarcoma cells. Cancer Res., 56, 3898-3901 (1996).
10. KEATING, M.T. and WILLIAMS, L.T., Autocrine stimulation of intracellular PDGF receptors in v-sis-transformed cells. Science, 239, 914-916 (1988).
11. KENNY, N.J., SAKEI, T., GOTTARDIS, M., KIM, N., GARCIA-MORALES, P., MARTIN, M.B., NORMANNO, N., CIARDIELLO, F., DAY, A., CUTLER, M.L. and SALOMON, D.S., Expression of transforming growth factor α antisense mRNA inhibits the estrogen-induced production of TGF α and estrogeninduced proliferation of estrogen-responsive human breast-cancer cells. J. cell. Physiol., 156, 497-514 (1993).
12. LANG, R.A., METCALF, D., CUTHBERTSON, R.A., LYONS, L. STANLEY, E., KELSO, A., KANNOURASKIS, G., WILLIAMSON, D.J., KLINTWORTH, G.K., GONDA, T.J. and DUNN, A.R., Autocrine stimulation of intercellular PDGF receptors in v-sis transformed cells. Cell, 43, 531-542 (1985).
13. MASSAOUÉ, J. and PANDIELLA, A., Membrane-anchored growth factors. Ann. Rev. Biochem., 62, 515-541 (1993).
14. MERCOLA, D. and COHEN, S.S., Antisense approaches to cancer therapy. Cancer Gene Ther., 2, 47-19 (1995).
15. MORONI, M.C., WILLINGHAM, M.C. and BEGUINOT, L., EGF-R antisense RNA blocks expression of the epidermal growth factor receptor and suppresses the transforming phenotype of a human carcinoma cell line. J. biol. Chem., 267, 2714-2722 (1992).
16. PROCHOWNIK, E.V., ERICKSON, R.P. and IZANT, J.G., Antisense approaches to assessing oncogene signal pathway. In: R.P. Erickson and J.G. Izant (eds.). Gene regulation: biology of antisense RNA and DNA. pp. 303-316, Raven Press, New York. (1992).
17. RAJAGOPAL, S., HUANG, S., MOSKAL, T.L., LEE, B-N., EL-NAGGAR, A.K. and CHAKRABARTY, S., Epidermal growth factor receptor expression in human colon and colon carcinomas: antisense epidermal growth factor receptor RNA regulates the proliferation of human colon-cancer cells. Int. J. Cancer, 62, 661-667 (1995).
18. RUSCH, V. BASELGA, J., CORDON-CARLDO, C. ORAZEM, J., ZAMAN, M., HODA, S., MCINTOSH, J., KURIE, J. and DMITROVSKY, E., Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung. Cancer Res., 53, 2379-2385 (1993).
19. SIZELAND, A.M. and BURGESS, A.W., Antisense transforming growth factor α oligonucleotides inhibit autocrine stimulated proliferation of a colon carcinoma cell line. Mol. Biol. Cell, 3, 1235-1243 (1992).
20. SPORN, M.B. and ROBERTS, A.B., Autocrine growth factors and cancer. Nature (Lond.), 313, 745-747 (1985).
21. SUGAWA, N., EKSTRAND, A.J., JAMES, C.D. and COLLINS, V.P., Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastomas. Proc. nat. Acad. Sci. (Wash.), 87, 8602-8606 (1990).
22. VON AHSEN, U. and SCHROEDRR, R., RNA as catalyst: natural and designed ribozymes. Bioassay, 15, 299-307 (1993).
23. WU, J.-X. and ADAMSON, E.D., Inhibition of differentiation in P19 embryonal-carcinoma cells by the expression of vectors encoding truncated or antisense EGF receptor. Dev. Biol., 159, 208-222 (1993).
24. ZHANG, W.W., Antisense oncogene and tumor-suppressor gene therapy of cancer. J. mol. Med., 74, 191-204 (1996).
25. ZHOU, S., JIANG, W., ZHANG, Y.-J., KAHN, S.M., SCHIEREN, I., SANTELLA, R.M. and WEINSTEIN, I.B., Antisense to cyclin D1 inhibits growth and reverses the transformed phenotype of human esophageal cancer cells. Oncogene, 11, 571-580 (1995).